Table 1

Clinical characteristics of study patients

Basal insulinOADp Value
Number of patients7575
Gender, n (F/M)49/2647/280.73
Age, years79±879±8.10.97
Race: black/white/other, n24/49/129/44/20.28
BMI, kg/m230±630±70.73
Diabetes duration, years8.6±4.97.7±5.20.15
HbA1C, %6.9±0.96.5±0.70.05
Previous diabetes therapy0.95
 Metformin, n (%)19 (25)21 (28) 
 Sulfonylurea (SU), n (%)21 (28)20 (27)
 DPP-4i, n (%)8 (11)6 (8)
 Other, n (%)27 (36)28 (37)
Comorbidities
 Hypertension, n (%)68 (91)61 (81)0.16
 Coronary heart disease, n (%)25 (36)22 (29)0.11
 Heart failure, n (%)29 (39)21 (28)0.17
 Acute kidney injury, n (%)21 (28)23 (31)0.72
 Dyslipidemia, n (%)34 (45)33 (44)0.87
 Dementia, n (%)27 (36)18 (24)0.11
 Mental illness, n (%)33 (44)25 (33)0.18
Admission area0.99
 Subacute Rehab70 (93)69 (92) 
 Long-term care5 (7)6 (8)
  • HbA1C, glycated hemoglobin; BMI, body mass index.